Literature DB >> 33111189

Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples.

Seth I Felder1, Sebastian Feuerlein2, Arthur Parsee2, Iman Imanirad3, Julian Sanchez3, Sophie Dessureault3, Richard Kim3, Sarah Hoffe3, Jessica Frakes3, James Costello2.   

Abstract

A nonoperative management strategy, or Watch-and-Wait, following neoadjuvant therapies of locally advanced rectal adenocarcinoma is increasingly considered for select patients. Yet, standardized tumor response assessment to best select and surveil suitable patients remains an unmet clinical challenge. Endoscopic and MRI currently provide the most reliable tumor response estimations. However, resources illustrating variable tumor responses to neoadjuvant therapies remain limited. This pictorial review aims to provide detailed and annotated examples of common endoscopic and MRI findings of rectal cancer treatment response, while also emphasizing their respective diagnostic shortcomings and consequently, the necessity for a multidisciplinary approach to optimally manage these patients.

Entities:  

Keywords:  Endoscopy; MRI; Nonoperative management; Organ preservation; Rectal cancer; Watch-and-Wait

Year:  2020        PMID: 33111189     DOI: 10.1007/s00261-020-02827-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  65 in total

Review 1.  A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.

Authors:  Fahima Dossa; Tyler R Chesney; Sergio A Acuna; Nancy N Baxter
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-05-04

2.  Patient and Physician Preferences for Nonoperative Management for Low Rectal Cancer: Is It a Reasonable Treatment Option?

Authors:  Erin D Kennedy; Anna M Borowiec; Selina Schmocker; Charles Cho; James Brierley; Shirley Li; J Charles Victor; Nancy N Baxter
Journal:  Dis Colon Rectum       Date:  2018-11       Impact factor: 4.585

3.  Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.

Authors:  Emmanouil Fokas; Michael Allgäuer; Bülent Polat; Gunther Klautke; Gerhard G Grabenbauer; Rainer Fietkau; Thomas Kuhnt; Ludger Staib; Thomas Brunner; Anca-Ligia Grosu; Wolff Schmiegel; Lutz Jacobasch; Jürgen Weitz; Gunnar Folprecht; Anke Schlenska-Lange; Michael Flentje; Christoph-Thomas Germer; Robert Grützmann; Matthias Schwarzbach; Vittorio Paolucci; Wolf O Bechstein; Tim Friede; Michael Ghadimi; Ralf-Dieter Hofheinz; Claus Rödel
Journal:  J Clin Oncol       Date:  2019-05-31       Impact factor: 44.544

4.  Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?

Authors:  Britt J P Hupkens; Monique Maas; Milou H Martens; Marit E van der Sande; Doenja M J Lambregts; Stéphanie O Breukink; Jarno Melenhorst; Janneke B Houwers; Christiaan Hoff; Meindert N Sosef; Jeroen W A Leijtens; Maaike Berbee; Regina G H Beets-Tan; Geerard L Beets
Journal:  Ann Surg Oncol       Date:  2017-11-13       Impact factor: 5.344

5.  Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Gregory Wynn; John Marks; Hermann Kessler; Joaquim Gama-Rodrigues
Journal:  Dis Colon Rectum       Date:  2010-12       Impact factor: 4.585

6.  Salvage surgery for local regrowths in Watch & Wait - Are we harming our patients by deferring the surgery?

Authors:  Irfan Nasir; Laura Fernandez; Pedro Vieira; Oriol Parés; Inês Santiago; Mireia Castillo-Martin; Hugo Domingos; Jose F Cunha; Carlos Carvalho; Richard J Heald; Geerard L Beets; Amjad Parvaiz; Nuno Figueiredo
Journal:  Eur J Surg Oncol       Date:  2019-04-13       Impact factor: 4.424

7.  Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.

Authors:  Angelita Habr-Gama; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Charles Sabbagh; Patricio B Lynn; Rodrigo O Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

8.  Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.

Authors:  Britt J P Hupkens; Milou H Martens; Jan H Stoot; Maaike Berbee; Jarno Melenhorst; Regina G Beets-Tan; Geerard L Beets; Stéphanie O Breukink
Journal:  Dis Colon Rectum       Date:  2017-10       Impact factor: 4.585

9.  Organ Preservation in Rectal Cancer: The Patients' Perspective.

Authors:  Cihan Gani; Nina Gani; Sebastian Zschaeck; Fabian Eberle; Norbert Schaeffeler; Thomas Hehr; Bernhard Berger; Stefan Georg Fischer; Johannes Claßen; Stephan Zipfel; Claus Rödel; Martin Teufel; Daniel Zips
Journal:  Front Oncol       Date:  2019-05-10       Impact factor: 6.244

10.  Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.

Authors:  J Joshua Smith; Oliver S Chow; Marc J Gollub; Garrett M Nash; Larissa K Temple; Martin R Weiser; José G Guillem; Philip B Paty; Karin Avila; Julio Garcia-Aguilar
Journal:  BMC Cancer       Date:  2015-10-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.